Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,518,008,348    

Indirect Value

   $7,546,182,718      
Total Shares   186,710,189      
Total Value   $10,064,191,065      


Neurocrine Biosciences Inc $704,088,488 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $47,110,150 Ligand Pharmaceuticals Inc $1,306,436,094 Curis Inc $3,390,252 Repligen Corp $455,929,095 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $704,088,488 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $47,110,150 Ligand Pharmaceuticals Inc $1,306,436,094 Curis Inc $3,390,252 Repligen Corp $455,929,095 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2003-07-17 4 B $3.90 $2,340 I/I 600 2,424,023 1.42 -
AMAG AMAG Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-07-25 4 B $8.99 $215,760 I/I 24,000 1,416,733 1.5 -
AMAG AMAG Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-08-13 4 B $8.78 $189,585 I/I 21,600 1,438,333 1.5 -
NTII Neurobiological Technolog... Indirect Beneficial Owner   –       –       •   2007-11-06 4 B $2.43 $114,083 I/I 47,000 4,938,393 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-09 4 B $4.29 $525,966 I/I 122,700 5,606,550 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-10 4 B $4.26 $1,415,268 I/I 324,227 5,930,777 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-14 4 B $4.50 $111,600 I/I 24,800 5,955,577 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-15 4 B $4.65 $498,655 I/I 107,300 6,062,877 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-23 4 B $4.47 $690,969 I/I 154,600 6,217,477 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-31 4 B $4.71 $2,404,548 I/I 510,000 6,727,477 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-01 4 B $5.00 $825,528 I/I 165,000 6,892,477 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-04 4 B $5.08 $1,068,085 I/I 210,100 7,102,577 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-07 4 B $4.90 $1,803,970 I/I 368,300 7,470,877 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-08 4 B $4.98 $1,289,406 I/I 259,000 7,729,877 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-11 4 B $4.96 $414,851 I/I 83,700 7,813,577 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-15 4 B $5.08 $252,072 I/I 49,600 7,863,177 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-19 4 B $5.10 $164,707 I/I 32,300 7,895,477 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-20 4 B $5.05 $141,905 I/I 28,100 7,923,577 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-21 4 B $4.95 $920,905 I/I 186,000 8,109,577 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-21 4 B $4.70 $498,582 I/I 106,000 3,340,300 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-22 4 B $4.84 $382,313 I/I 79,000 3,419,300 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-22 4 B $4.75 $38,950 I/I 8,200 8,117,777 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-25 4 B $4.96 $535,205 I/I 108,000 3,527,300 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-26 4 B $5.00 $103,975 I/I 20,800 3,890,100 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-28 4 B $5.00 $115,000 I/I 23,000 3,913,100 1.5 -
  195  Records found
  1  2   3   4   5   6   7   8      
  Page 1 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us